BERLIN (Reuters) – Germany continues to use AstraZeneca’s COVID-19 vaccine according to the European Medicines Agency’s guidelines despite reports about serious side-effects and a suspension of the vaccine in some countries, the health ministry said.
The reports of potential safety risks are taken seriously and data is examined constantly, a ministry spokesman told Reuters. Further proceedings will be discussed with the European and the national vaccine regulators this week, he said.
(Reporting by Andreas Rinke, writing by Kirsti Knolle, editing by Riham Alkousaa)